113 related articles for article (PubMed ID: 2674085)
21. The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence.
Schupak K; Malkin M; Anderson L; Arbit E; Lindsley K; Leibel S
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1167-76. PubMed ID: 7607939
[TBL] [Abstract][Full Text] [Related]
22. Theoretical basis and clinical methodology for stereotactic interstitial brain tumor irradiation using iododeoxyuridine as a radiation sensitizer and 145Sm as a brachytherapy source.
Goodman JH; Gahbauer RA; Kanellitsas C; Clendenon NR; Laster BH; Fairchild RG
Stereotact Funct Neurosurg; 1990; 54-55():531-4. PubMed ID: 1964244
[TBL] [Abstract][Full Text] [Related]
23. [Interstitial brachytherapy in malignant gliomas].
Hoshino T
Gan No Rinsho; 1989 Sep; 35(11):1355-61. PubMed ID: 2681874
[TBL] [Abstract][Full Text] [Related]
24. [Computerized system of dosimetric planning of interstitial multiposition stereotaxic irradiation in neutron therapy of brain tumors].
Shkol'nik FG; Melikian AG; Liass FM; Borodkin SM; Chekhonadskiĭ VN; Spasokukotskaia ON; Elisiutin GP
Med Radiol (Mosk); 1991; 36(4):44-8. PubMed ID: 2034088
[TBL] [Abstract][Full Text] [Related]
25. Dose volume assessment of high dose rate 192Ir endobronchial implants.
Saw CB; Korb LJ; Pawlicki T; Wu A
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):917-22. PubMed ID: 8598371
[TBL] [Abstract][Full Text] [Related]
26. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Viola A; Major T; Julow J
Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
[TBL] [Abstract][Full Text] [Related]
27. Improved precision of interstitial brain tumor irradiation using the BRW CT stereotaxic guidance system.
Sapozink MD; Moeller JM; McDonald PN; Heilbrun MP
Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1753-60. PubMed ID: 3312130
[TBL] [Abstract][Full Text] [Related]
28. Interseed effects on dose for 125I brachytherapy implants.
Meigooni AS; Meli JA; Nath R
Med Phys; 1992; 19(2):385-90. PubMed ID: 1584137
[TBL] [Abstract][Full Text] [Related]
29. [The technique of stereotactic I125 brachytherapy (permanent implants) of brain tumors in Vienna].
Hawliczek R; Grunert P; Ferraz-Leite H; Alesch F
Strahlenther Onkol; 1990 Oct; 166(10):647-9. PubMed ID: 2173160
[TBL] [Abstract][Full Text] [Related]
30. Comparison of static conformal field with multiple noncoplanar arc techniques for stereotactic radiosurgery or stereotactic radiotherapy.
Hamilton RJ; Kuchnir FT; Sweeney P; Rubin SJ; Dujovny M; Pelizzari CA; Chen GT
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1221-8. PubMed ID: 7493846
[TBL] [Abstract][Full Text] [Related]
31. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
Lin L; Patel RR; Thomadsen BR; Henderson DL
Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
[TBL] [Abstract][Full Text] [Related]
32. The clinical advantages of I-125 seeds as a substitute for Ir-192 seeds in temporary plastic tube implants.
Clarke DH; Edmundson GK; Martinez A; Matter RC; Vicini F; Sebastian E
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):859-63. PubMed ID: 2777677
[TBL] [Abstract][Full Text] [Related]
33. Improved dose distribution with customized I-125 source loading in temporary interstitial implants.
Ling CC; Huang DY; Barnett C; Goffinet D; Mariscal M; Roberts LW; Fu KK; Phillips T
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):769-74. PubMed ID: 3417495
[TBL] [Abstract][Full Text] [Related]
34. The importance of postoperative CT image fusion verification of stereotactic interstitial irradiation for brain tumors.
Viola A; Major T; Julow J
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):322-8. PubMed ID: 15337571
[TBL] [Abstract][Full Text] [Related]
35. Reference dose rates for single- and double-plane 192Ir implants.
Saw CB; Suntharalingam N
Med Phys; 1988; 15(3):391-6. PubMed ID: 3405143
[TBL] [Abstract][Full Text] [Related]
36. From manual to 3-D computerized treatment planning for 125-I stereotactic brain implants.
Ten Haken RK; Diaz RF; McShan DL; Fraass BA; Taren JA; Hood TW
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):467-80. PubMed ID: 3042720
[TBL] [Abstract][Full Text] [Related]
37. Advantages of using high activity 125I seeds in temporary interstitial breast implants.
Rustgi SN; Hahn SS
Med Dosim; 1992; 17(4):217-20. PubMed ID: 1485911
[TBL] [Abstract][Full Text] [Related]
38. Late considerations in the treatment of low-grade malignancy cerebral tumors with iodine-125 brachytherapy.
Frank F; Fabrizi AP; Gaist G; Frank-Ricci R; Piazzi M; Spagnolli F
Appl Neurophysiol; 1987; 50(1-6):302-9. PubMed ID: 3329868
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
Meigooni AS; Luerman CM; Sowards KT
Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
[TBL] [Abstract][Full Text] [Related]
40. Response of extra-axial tumors to stereotactically implanted high-activity 125I seeds.
Patil AA; Kumar P; Leibrock LG
Stereotact Funct Neurosurg; 1995; 64(3):139-52. PubMed ID: 8746503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
